BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,055 filers reported holding BAXTER INTL INC in Q2 2022. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,489 | -15.9% | 120,103 | +0.3% | 0.01% | -16.7% |
| Q2 2023 | $5,336 | -56.1% | 119,731 | -60.7% | 0.01% | -61.3% |
| Q1 2023 | $12,153 | +6.2% | 304,408 | +35.2% | 0.03% | +3.3% |
| Q4 2022 | $11,439 | -99.9% | 225,158 | -15.3% | 0.03% | -30.2% |
| Q3 2022 | $14,626,000 | -62.1% | 265,837 | -55.3% | 0.04% | -61.6% |
| Q2 2022 | $38,621,000 | -20.9% | 594,840 | -3.5% | 0.11% | -5.9% |
| Q1 2022 | $48,822,000 | -10.9% | 616,136 | -2.5% | 0.12% | -10.5% |
| Q4 2021 | $54,812,000 | +7.8% | 631,619 | +1.5% | 0.13% | -6.3% |
| Q3 2021 | $50,867,000 | +23.1% | 622,052 | +22.0% | 0.14% | +17.4% |
| Q2 2021 | $41,328,000 | -12.4% | 509,747 | -8.1% | 0.12% | -22.9% |
| Q1 2021 | $47,185,000 | +20.2% | 554,796 | +13.4% | 0.16% | +6.8% |
| Q4 2020 | $39,257,000 | +9.0% | 489,382 | +6.3% | 0.15% | -8.1% |
| Q3 2020 | $36,030,000 | +122.5% | 460,454 | +138.0% | 0.16% | +56.9% |
| Q2 2020 | $16,193,000 | +28.9% | 193,438 | +26.1% | 0.10% | +6.2% |
| Q1 2020 | $12,558,000 | -5.2% | 153,373 | -3.4% | 0.10% | +18.5% |
| Q4 2019 | $13,253,000 | -60.6% | 158,788 | -59.3% | 0.08% | -61.2% |
| Q3 2019 | $33,631,000 | -35.0% | 389,668 | -38.3% | 0.21% | -19.3% |
| Q2 2019 | $51,723,000 | +211.0% | 631,847 | +183.6% | 0.26% | +161.6% |
| Q1 2019 | $16,633,000 | -15.3% | 222,825 | -25.2% | 0.10% | -23.8% |
| Q4 2018 | $19,631,000 | +18.0% | 297,980 | +33.7% | 0.13% | +32.7% |
| Q3 2018 | $16,633,000 | +3.8% | 222,825 | +3.4% | 0.10% | -5.8% |
| Q2 2018 | $16,027,000 | -1.2% | 215,399 | -14.2% | 0.10% | -6.3% |
| Q1 2018 | $16,215,000 | +40.9% | 251,152 | +35.2% | 0.11% | +24.7% |
| Q4 2017 | $11,508,000 | +0.5% | 185,750 | +0.5% | 0.09% | 0.0% |
| Q3 2017 | $11,452,000 | +4.6% | 184,850 | +2.8% | 0.09% | +2.3% |
| Q2 2017 | $10,944,000 | +32.6% | 179,737 | +14.3% | 0.09% | +14.5% |
| Q1 2017 | $8,255,000 | +23.3% | 157,226 | +4.0% | 0.08% | +7.0% |
| Q4 2016 | $6,694,000 | -45.4% | 151,231 | -42.0% | 0.07% | -47.8% |
| Q3 2016 | $12,266,000 | +18.2% | 260,734 | +12.8% | 0.14% | +15.3% |
| Q2 2016 | $10,373,000 | +47.6% | 231,215 | +35.6% | 0.12% | +42.2% |
| Q1 2016 | $7,030,000 | +26.6% | 170,451 | +18.1% | 0.08% | +29.7% |
| Q4 2015 | $5,555,000 | +1.9% | 144,351 | -12.3% | 0.06% | -3.0% |
| Q3 2015 | $5,452,000 | -62.7% | 164,661 | -19.9% | 0.07% | -61.8% |
| Q2 2015 | $14,621,000 | +0.4% | 205,553 | -3.4% | 0.17% | -4.9% |
| Q1 2015 | $14,568,000 | -16.2% | 212,732 | -9.0% | 0.18% | -16.9% |
| Q4 2014 | $17,381,000 | +6.2% | 233,644 | +2.6% | 0.22% | -1.4% |
| Q3 2014 | $16,363,000 | +16.7% | 227,674 | +18.5% | 0.22% | +5.2% |
| Q2 2014 | $14,017,000 | -5.4% | 192,072 | -5.5% | 0.21% | -10.2% |
| Q1 2014 | $14,818,000 | +6.1% | 203,183 | +1.0% | 0.24% | +2.6% |
| Q4 2013 | $13,963,000 | -15.1% | 201,132 | -19.1% | 0.23% | -20.8% |
| Q3 2013 | $16,454,000 | +16.4% | 248,701 | +22.7% | 0.29% | +4.3% |
| Q2 2013 | $14,132,000 | – | 202,707 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |